Search
for
Sort by
Research 121–150 of 1000+
- Foxp3 Post-translational Modifications and Treg Suppressive Activity
- p53‐dependent transcriptional regulation of EDA2R and its involvement in chemotherapy‐induced hair loss
- Calcitonin gene‐related peptide (CGRP) may award relative protection from interferon‐γ‐induced collapse of human hair follicle immune privilege
- Synchronizing actin and microtubules for axonal branching
- SUMMARIES OF PAPERS
- Modification of the immune system with hydrogen sulfide and cyclosporine A
- TGFβ and cancer metastasis: an inflammation link
- UTMD Enhances Targeting of Diclofenac and Doxil® to Boost Tumor Immunotherapy
- Bone Morphogenetic Protein Antagonist Noggin Promotes Skin Tumorigenesis via Stimulation of the Wnt and Shh Signaling Pathways
- BRCA2 in abscission
- Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation
- The role of <i>Atg5</i> gene in tumorigenesis under autophagy deficiency conditions
- Targeting receptor–regulator interactions
- Why we should treat COVID-19 Long-Hauler Syndromes with Convalescent Plasma; Contained Suppressive Exosomes are likely COVID antigen-specific
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- Signal integrator function of CXXC5 in Cancer
- Clinical Snippets
- Chaperones as thermodynamic sensors
- Zinc as an essential element for normal immune reactions and as a therapeutic agent for autoimmune diseases
- Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies
- Molecular mechanisms of viral oncogenesis in humans
- Frequent downregulation of DMBT1 and galectin‐3 in epithelial skin cancer
- Clinical perspectives on the age-related increase of immunosuppressive activity
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- RAGE and Its Ligands in Melanoma
- Novel Insights into TSC22D Family Genes in Metabolic Diseases and Cancer
- Hepatology highlights
- 415 IL-17C: Checkpoint in innate skin immunology
- Metformin and Malignant Tumors: Not Over the Hill
- SASH1 Mutations and Hereditary Disorders of Pigmentation: Review of Literature